The Therapeutic Effect of Melatonin on GC by Inducing Cell Apoptosis and Autophagy Induced by Endoplasmic Reticulum
Yanshan Zheng1, Jiawei Tu1, Xinxin Wang1
1Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, People's Republic of China.
Background:
Gastric cancer (GC) is the main malignancy affecting a large population worldwide. Lack of effective enough treatment is one of the leading factors contributing to the high mortality rate. Melatonin, a naturally occurring compound, has been proven to exert cytotoxic and antiproliferative effects on human gastric cancers. Nevertheless, the mechanisms of anti-gastric cancer of melatonin remain elucidated. It is believed that endoplasmic reticulum (ER) stress and its resultant unfolded protein response (UPR) are connected to the survival, progression, and chemoresistance of various tumor cells via multiple cellular procedures, such as autophagy. In this study, the effects of melatonin on human gastric cancer cell lines AGS and SGC-7901 was assessed to reveal the interaction between melatonin, endoplasmic reticulum stress, and autophagy in gastric cancer.
Methods:
CCK-8, the wound healing analysis, colony formation assay, immunofluorescence analysis, Western blotting, flow cytometry, and animal models were used in the current study.
Results:
The data demonstrated that melatonin could inhibit GC growth, proliferation, and invasion both in vivo and in vitro. Apoptosis and autophagy induced in a concentration-dependent manner is response to melatonin-induced ER stress. Melatonin induced the expression of apoptotic and autophagy-related proteins, which was markedly attenuated by the ER stress inhibitor 4-PBA and autophagy inhibitor 3-MA. In addition, we used the specific IRE1 inhibitor STF 083010, finding that inhibiting IRE1 could considerably relieve ER stress-induced autophagy activity, as revealed by the reduction of LC3-II and Beclin-1.
Conclusion:
This study confirmed that melatonin-induced inhibition of GC cell proliferation is mediated by the activation of the IRE/JNK/Beclin1 signaling.
Insights
Melatonin inhibits gastric cancer (GC) growth by inducing endoplasmic reticulum (ER) stress, leading to apoptosis and autophagy. This process is mediated by the IRE1/JNK/Beclin1 signaling pathway, offering a potential therapeutic strategy for GC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Gastric cancer (GC) presents a significant global health challenge with high mortality rates due to limited effective treatments.
- Melatonin, a natural compound, exhibits anti-cancer properties, but its precise mechanisms in GC remain unclear.
- Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are implicated in tumor progression and chemoresistance, often involving autophagy.
Purpose of the Study:
- To investigate the effects of melatonin on human gastric cancer cell lines (AGS and SGC-7901).
- To elucidate the interaction between melatonin, ER stress, and autophagy in the context of gastric cancer.
- To identify the specific signaling pathways involved in melatonin's anti-gastric cancer effects.
Main Methods:
- Cell viability (CCK-8), migration (wound healing), and colony formation assays were performed.
- Immunofluorescence, Western blotting, and flow cytometry were utilized to assess cellular processes.
- In vivo animal models were employed to evaluate melatonin's efficacy and mechanisms.
Main Results:
- Melatonin demonstrated significant inhibition of gastric cancer growth, proliferation, and invasion both in vitro and in vivo.
- Melatonin induced apoptosis and autophagy in a concentration-dependent manner, linked to ER stress.
- Inhibition of ER stress (4-PBA) and autophagy (3-MA) attenuated melatonin's effects; IRE1 inhibition reduced autophagy markers (LC3-II, Beclin-1).
Conclusions:
- Melatonin effectively inhibits gastric cancer cell proliferation through the induction of ER stress.
- The study identified the IRE1/JNK/Beclin1 signaling pathway as crucial for melatonin's anti-gastric cancer activity.
- Melatonin represents a promising therapeutic agent for gastric cancer, with its action mediated by ER stress and autophagy.
More Related Videos
06:42A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Related Concept Videos
Management of Insomnia
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
